Selected References: Abdel-Aleem H, et al. 2003. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol; 108(1):25-8. Abdelshafy A, et al. 2019. Sublingual vs vaginal misoprostol for completion of first trimester missed abortion: a randomised controlled trial. Eur J Contracept Reprod Health Care 12: 1-6. Ameri A, et al. 2024. Effect of misoprostol versus oxytocin on delivery …
The Baby Blog
About Our Baby Blog
Every person wants to know what’s best for their baby, especially when it comes to knowing how to minimize exposure risks. Our relatable stories are packed with practical information from our rotating staff of MotherToBaby expert bloggers. Whatever topic you’re looking for, our blogs will provide you a great foundation to learn more.
Nirmatrelvir/Ritonavir (Paxlovid®)
Selected References: American College of Obstetricians and Gynecologists (ACOG). 2020 (with ongoing updates). COVID-19 FAQs for obstetrician-gynecologists, obstetrics. Available at https://www.acog.org/clinical-information/physician-faqs/covid-19-faqs-for-ob-gyns-obstetrics. Retrieved May 19, 2024. Anderson PO. 2022. COVID-19 drugs and breastfeeding update. Breastfeed Med. 17:377–9. Chourasia P, et al. 2023. Paxlovid (nirmatrelvir and ritonavir) use in pregnant and lactating woman: …
Lurasidone (Latuda®)
Selected References: Cohen LS, et al. 2023. Reproductive safety of lurasidone and quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications. J Womens Health (Larchmt). 32(4):452-462. Cruz MP. 2011. Lurasidone HCl (Latuda), an oral, once-daily atypical antipsychotic agent for the treatment of patients with schizophrenia. P & T : a peer-reviewed journal for formulary management, 36(8):489–492. Damkier, P & Videbech, P. 2018. The safety of …
Progesterone and Progestins
Selected References: Carmichael SL, et.al. 2005. Maternal progestin intake and risk of hypospadias. Archives of Pediatrics & Adolescent Medicine, 159(10):957-962. Check JH, et al. 1986. The risk of fetal anomalies as a result of progesterone therapy during pregnancy. Fertil Steril, 45:575-577. Committee on Drugs. 2001. The transfer of drugs and other chemicals into human milk. Pediatrics, 108(3):776-789. American College of Obstetricians and Gynecologists’ Committee on Practice …
Abatacept (Orencia®)
Selected References Bristol-Myers Squibb. 2019. Available at https://clinicaltrials.gov/ct2/show/record/NCT01087125?view=record Dernoncourt A, et al. 2023. Fetal and neonatal adverse drug reactions associated with biologics taken during pregnancy by women with autoimmune diseases: Insights from an analysis of the World Health Organization pharmacovigilance database (VigiBase®). BioDrugs, 37(1):73-87. E.R. Squibb and Sons, L.L.C. (Last updated: October 30, 2023). Orencia drug label. …
